Related Books
Language: en
Pages: 720
Pages: 720
Type: BOOK - Published: 2016-12-19 - Publisher: John Wiley & Sons
Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all asp
Language: en
Pages: 623
Pages: 623
Type: BOOK - Published: 2016-08-12 - Publisher: Springer
This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Ind
Language: en
Pages:
Pages:
Type: BOOK - Published: 2018 - Publisher:
Similar biotherapeutic products (SBPs), also called biosimilars, exhibit similar biological and clinical properties to authorized reference products. Biosimilar
Language: en
Pages: 260
Pages: 260
Type: BOOK - Published: 2021-08-03 - Publisher: Elsevier
Monoclonal antibodies (mAbs) are naturally occurring complex biomolecules. New engineering methods have turned mAbs into a leading therapeutic modality for addr
Language: en
Pages: 0
Pages: 0
Type: BOOK - Published: 2020 - Publisher:
In the last decade, the expiration of patents protecting therapeutic monoclonal antibodies opened an opportunity for the development and approval of biosimilar